Invention Grant
- Patent Title: Autoantigens for diagnosis of rheumatoid arthritis
-
Application No.: US15571734Application Date: 2016-05-12
-
Publication No.: US10429379B2Publication Date: 2019-10-01
- Inventor: Allen C. Steere , Elise E. Drouin
- Applicant: THE GENERAL HOSPITAL CORPORATION
- Applicant Address: US MA Boston
- Assignee: THE GENERAL HOSPITAL CORPORATION
- Current Assignee: THE GENERAL HOSPITAL CORPORATION
- Current Assignee Address: US MA Boston
- Agency: Nixon Peabody LLP
- Agent David S. Resnick; Shayne Y. Huff
- International Application: PCT/US2016/032077 WO 20160512
- International Announcement: WO2016/183310 WO 20161117
- Main IPC: G01N33/50
- IPC: G01N33/50 ; G01N33/564 ; G01N33/569 ; G01N33/68

Abstract:
Disclosed herein are methods of diagnosing Rheumatoid arthritis in a subject comprising determining whether the subject is immunologically reactive with N-acetylglucosamine-6-sulfatase and/or filamin-A, wherein immunological reactivity of the subject to one or more of N-acetylglucosamine-6-sulfatase or filamin-A, as compared to an appropriate control, indicates the subject has rheumatoid arthritis. Examples of specific assays and kits for use with the methods are also disclosed.
Public/Granted literature
- US20180156778A1 AUTOANTIGENS FOR DIAGNOSIS OF RHEUMATOID ARTHRITIS Public/Granted day:2018-06-07
Information query
IPC分类: